Decades of animal and human research in the field of gut hormones have produced effective and safe therapies for the treatment of diabetes and obesity with the GLP1R agonists now accepted as routine treatments for diabetes and obesity. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.